ESG News For ABIOMED, Inc.
These sites contributed news to this page:
-
Analysis of randomized controlled trial data shows non-Caucasian high-risk PCI patients significantly benefit from Impella-support
We use cookies to improve the usability of our site and to analyze traffic patterns so we can improve our utility. Please agree to our use of cookies.